BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Medium (6M)
HDFC Securities Recommends 'Buy' On Jubilant Life Sciences
According to HDFC Securities, there are several tailwinds that will ensure profitability for Jubilant Life Sciences, including a strong product pipeline and a rain in market share in venoms and radio pharma. Additionally, the planned IPO for subsidiary is expected to lead to significant debt reduction for the company, the brokerage adds.